OW100S

FDA 510(k) K233937 · Softwave/Trt, LLC

Substantially Equivalent

510(k) numberK233937

Submission

Device name
OW100S
Applicant
Softwave/Trt, LLC
Woodstock, GA, US
Received
December 14, 2023
Decision date
July 9, 2024
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
PZL – Extracorporeal Shock Wave Device For Treatment Of Diabetic Foot Ulcers
Device class
Class II (moderate risk)
Regulation
21 CFR 878.4685
Specialty
General, Plastic Surgery

Treatment of diabetic foot ulcers

Other 510(k)s with product code PZL

510(k)DeviceApplicantDecision
K243279DOLORCLAST Focused Shock WavesPZL · Traditional E.M.S Electro Medical Systems S.A08/13/2025SE
K250779CS-Pro MEDPZL · Traditional Curative Sound Therapeutics07/02/2025SE
K231710OW100SPZL · Traditional Softwave/Trt, LLC09/01/2023SE
K202112Storz Medical Duolith SD1 T-Top & Tower System with C-Actor Sepia HandpiecePZL · Traditional Storz Medical AG02/21/2021SE
K200926OrthoGold 100PZL · Traditional Tissue Regeneration Technologies, LLC08/28/2020SE
K191961OrthoGoldPZL · Traditional Tissue Regeneration Technologies11/26/2019SE

More from Tissue Regeneration Technologies

510(k)DeviceDecision
K231710OW100SPZL · Traditional 09/01/2023SE

Questions and answers

When was OW100S cleared by the FDA?

OW100S (K233937) received a 510(k) decision of Substantially Equivalent on July 9, 2024, 208 days after the submission was received.

What is the product code of K233937?

The FDA product code is PZL – Extracorporeal Shock Wave Device For Treatment Of Diabetic Foot Ulcers, a Class II (moderate risk) device regulated under 21 CFR 878.4685.